18,284 resources
By Version
By Authority
Start Prev Rows 7400 - 7600 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1779 | Genital herpes (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1786 | Elevated liver enzyme (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1792 | Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1893 | Toxoplasmosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1927 | Coronary artery aneurysm (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1929 | Shock (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1932 | Oral mucosa Inflammation (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1936 | Strongyloidiasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1954 | La Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1955 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1956 | La Crosse Virus Diseases (Tests for La Crosse Virus Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1957 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1958 | Trivittatus Virus Diseases (Tests for Trivittatus Virus Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1965 | Encephalomyelitis (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1967 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1969 | Hepatitis D Virus Infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1970 | NU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1971 | Hepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1972 | Hepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1976 | Baylisascariasis (Tests for Baylisascaris species Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1979 | Larva Migrans (Neural, Ocular, or Visceral) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1981 | California Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1983 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1984 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1985 | California Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1986 | Pregnant (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1990 | Abscess (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1993 | Pathologic Fractures [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1995 | Granulomas (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1997 | Skin Lesions (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2000 | Lymphocytic Choriomeningitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2002 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2003 | Lymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2004 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2005 | Lymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2006 | Angiostrongyliasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2009 | Angiostrongyliasis (Tests for Angiostrongylus Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2010 | Eosinophils [Concentration] (Tests in CSF by Any Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2011 | Eosinophils [Percentage] (Tests in CSF by Any Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2012 | Mpox (Tests for mpox virus by Genomic Sequencing) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2013 | Mpox (Test Panels for mpox virus by Genomic Sequencing) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2018 | Interpretation of an Observation (High) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2019 | Interpretation of an Observation (Low) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2026 | Animal Bite or Scratch [Cat] (Disorders) (ICD10CM) | active | 2024-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2028 | Bartonellosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2033 | Bartonella henselae infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2034 | Bartonella quintana infection (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2053 | Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2055 | Cystic Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2057 | Alveolar Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2063 | Genital Warts (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2065 | Diphyllobothriasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) | active | 2023-06 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2072 | Pelvic Inflammatory Disease (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2073 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2074 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2076 | Lower Abdominal Tenderness (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) | active | 2024-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2081 | Leukocytosis (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) | active | 2025-02 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2084 | Pelvic Abscess (ICD10CM) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) | active | 2023-01 | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) | active | 2023-01 | hl7 |